Resources from the same session
1638 - Efficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study
Presenter: Fabrice Barlesi
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
4648 - Prognostic role of the EANO ESMO classification of leptomeningeal metastases
Presenter: Emilie Le Rhun
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
4361 - A Phase 0/2 Clinical Trial of a CDK4/6 Inhibitor in Aggressive Meningioma Patients
Presenter: Nader Sanai
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
1170 - Is Immuno-Oncology Therapy Effective in Hypermutator Glioblastomas with Somatic or Germline mutations ?
Presenter: Carlos Kamiya-Matsuoka
Session: Proffered Paper – CNS tumours
Resources:
Abstract
1688 - Health-related quality of life (HRQoL) evaluation in the REGOMA trial: a randomized, phase II clinical trial analyzing regorafenib activity in relapsed glioblastoma patients
Presenter: Mario Caccese
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
Proffered Paper – CNS tumours - Invited Discussant 392O, 393O and 394O
Presenter: Juan Sepulveda Sanchez
Session: Proffered Paper – CNS tumours
Resources:
Slides
Webcast